IRIXIRIDEX CORP

Nasdaq iridex.com


$ 2.65 $ -0.43 (-13.96 %)    

Wednesday, 15-May-2024 15:59:22 EDT
QQQ $ 452.83 $ 6.97 (1.56 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.09 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 2.65
$ 2.58
$ 0.00 x 0
$ 0.00 x 0
$ 2.58 - $ 2.78
$ 1.31 - $ 3.65
125,573
na
43.07M
$ 1.34
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-30-2024 10-Q
2 03-29-2024 12-30-2023 10-K
3 11-20-2023 09-30-2023 10-Q
4 08-10-2023 07-01-2023 10-Q
5 05-11-2023 04-01-2023 10-Q
6 03-09-2023 12-31-2022 10-K
7 11-10-2022 10-01-2022 10-Q
8 08-15-2022 07-02-2022 10-Q
9 05-12-2022 04-02-2022 10-Q
10 03-15-2022 01-01-2022 10-K
11 11-12-2021 10-02-2021 10-Q
12 08-12-2021 07-03-2021 10-Q
13 05-12-2021 04-03-2021 10-Q
14 03-23-2021 01-02-2021 10-K
15 11-10-2020 09-26-2020 10-Q
16 08-10-2020 06-27-2020 10-Q
17 05-12-2020 03-28-2020 10-Q
18 03-13-2020 12-28-2019 10-K
19 11-08-2019 09-28-2019 10-Q
20 08-07-2019 06-29-2019 10-Q
21 05-07-2019 03-30-2019 10-Q
22 03-29-2019 12-29-2018 10-K
23 11-06-2018 09-29-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 03-14-2018 12-30-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-08-2017 07-01-2017 10-Q
29 05-09-2017 04-01-2017 10-Q
30 03-15-2017 12-31-2016 10-K
31 11-07-2016 10-01-2016 10-Q
32 08-08-2016 07-02-2016 10-Q
33 05-09-2016 04-02-2016 10-Q
34 03-31-2016 01-02-2016 10-K
35 11-10-2015 10-03-2015 10-Q
36 08-10-2015 07-04-2015 10-Q
37 05-12-2015 04-04-2015 10-Q
38 04-02-2015 01-03-2015 10-K
39 11-03-2014 09-27-2014 10-Q
40 08-04-2014 06-28-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 stifel-maintains-hold-on-iridex-maintains-2-price-target

Stifel analyst Thomas Stephan maintains Iridex (NASDAQ:IRIX) with a Hold and maintains $2 price target.

 iridex-q1-2024-gaap-eps-021-misses-012-estimate-sales-1176m-miss-1200m-estimate

Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.12) by 7...

 iridex-q4-earnings-insights
Iridex: Q4 Earnings Insights
03/26/2024 20:30:08

 iridex-q4-2023-gaap-eps-018-misses-005-estimate-sales-12458m-miss-14900m-estimate

Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.05) by 2...

 earnings-scheduled-for-march-26-2024

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on reve...

 iridexs-earnings-outlook
Iridex's Earnings Outlook
03/25/2024 16:00:50

 iridex-corporation-receives-european-patent-on-micropulse-technology-ep-3009093-entitled-laser-system-with-short-pulse-characteristics-and-its-methods-of-use

Iridex Corporation (NASDAQ:IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery d...

 iridex-announces-first-patient-enrollment-in-micropulse-tlt-clinical-study-conducted-in-collaboration-with-imperial-college-healthcare-nhs-trust

Iridex Corporation, headquartered in Mountain View, California, and Imperial College Healthcare NHS Trust in London, today anno...

 iridex-says-all-five-medicare-administrative-contractors-retired-their-local-coverage-determinations-that-were-scheduled-to-take-effect-on-january-29-2024

Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery ...

 iridex-q3-eps-011-beats-012-estimate-sales-1285m-miss-1348m-estimate

Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.12) by 8.3...

 iridex-q3-earnings-insights
Iridex: Q3 Earnings Insights
11/14/2023 21:55:13

 earnings-scheduled-for-november-14-2023

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

 dow-gains-over-100-points-fed-leaves-interest-rates-unchanged

U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision. The Dow traded u...

 why-extreme-networks-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Gainers

 nasdaq-surges-over-100-points-ahead-of-fed-decision-wework-shares-plunge

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Wednesday. The Dow...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION